Fresenius pulls out of Akorn acquisition

23 April 2018 - Deborah Wilkes


German healthcare company Fresenius is pulling out of its planned USD4.75 billion acquisition of US generics, OTC and animal health company Akorn.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: